We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Transplant-Surgery System Maintains Viable Organs

By HospiMedica staff writers
Posted on 26 Jun 2006
A new transplant-surgery system may make it possible to transplant organs that would otherwise not be transplantable. More...


The system is designed to maintain and improve organ health, increase the amount of time that an organ can remain outside the body, give surgeons the opportunity to assess and potentially improve the function of the organ, and increase the availability of viable organs for transplant. The TransMedics organ care system, developed by Transmedics (Andover, MA, USA), includes a specialized machine that, for example, keeps a heart beating and warm until it is ready to be used. This eliminates the need for packing the heart in ice, as the current method requires. The system is currently limited to investigational use in the United States.

The system incorporates technologies that simulate the conditions of the human body and allow the organ to function as it normally does. At the core of the system is the perfusion module, a transparent, sterile chamber designed to protect the organ and maintain the appropriate warm temperature, humidity, and solutions required for organ maintenance. Donor blood is used, and the system provides for blood oxygenation and flow from an internal gas supply and pulsatile pumping system. A proprietary solution is infused to replenish depleted nutrients and other necessary substrates in the blood. The system also protects the organ from contamination. Finally, a compact wireless monitor provides important information to allow assessment of the organ by a physician. In the case of the heart, parameters such as aortic pressure, coronary flow, blood temperature, and heart rate are monitored.

The system enables full functional, biochemical, and metabolic assessment of the organ, and may enable the utilization of organs that are currently wasted due to the limitation of the existing preservation method, by allowing the transplant surgeon the time to potentially resuscitate the organ ex vivo to build up its energy stores, optimize its function, and perform full viability assessment prior to transplantation.



Related Links:
Transmedics

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.